|
|
| | 1H-Indole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- Basic information |
| | 1H-Indole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- Chemical Properties |
| Boiling point | 660.8±50.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | solubility | DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml; Ethanol: 2 mg/ml | | form | A crystalline solid | | pka | 13.34±0.46(Predicted) |
| | 1H-Indole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- Usage And Synthesis |
| Description | ADB-FUBICA is an analytical reference material that is structurally categorized as a synthetic cannabinoid (CB). It is an agonist of both CB receptors (EC50s = 2.6 and 3.0 nM for CB1 and CB2, respectively).1,2 This product is intended for research and forensic applications. | | References | 1. Banister, S.D., Moir, M., Stuart, J., et al. Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA ACS Chem. Neurosci. 6(9),1546-1559(2015). 2. Qian, Z., Hua, Z., Liu, C., et al. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances Forensic Toxicol. 34,133-143(2016). |
| | 1H-Indole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- Preparation Products And Raw materials |
|